Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.350
+0.010 (0.75%)
At close: Nov 4, 2024, 4:00 PM
1.380
+0.030 (2.22%)
After-hours: Nov 4, 2024, 7:44 PM EST
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $17.34 million as of November 5, 2024.
Market Cap
17.34M
Enterprise Value
18.10M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $51.37M to $17.34M, a decrease of -66.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 17.30M | -66.32% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ekso Bionics Holdings | 19.00M |
| Cocrystal Pharma | 18.92M |
| bioAffinity Technologies | 18.62M |
| Marinus Pharmaceuticals | 18.59M |
| Bullfrog AI | 18.16M |
| NeurAxis | 17.68M |
| TherapeuticsMD | 17.62M |
| Lyra Therapeutics | 17.08M |